Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum

Behav Brain Res. 2013 May 1:244:58-65. doi: 10.1016/j.bbr.2013.01.028. Epub 2013 Jan 31.

Abstract

An herb derived compound, levo-tetrahydropalmatine (L-THP), attenuates self-administration of cocaine and opiates in rodents. Since L-THP mainly antagonizes dopamine D2 receptors (D2R) in the brain, it is likely to regulate other addictive behaviors as well. Here, we examined whether L-THP regulates ethanol drinking in C57BL/6J mice using a two-bottle choice drinking experiment. L-THP treated mice consumed less ethanol compared to vehicle-treated mice during the 15% ethanol drinking session while water consumption remained similar between each group. We then examined the molecular basis underlying the pharmacological effect of L-THP in mice. Our results indicated that a single injection of L-THP increased active phosphorylated forms of PKA, AKT and ERK in the caudate-putamen (CPu), but not in the nucleus accumbens (NAc), of alcohol naïve mice. Interestingly, we found that systematic treatment with L-THP for 4 consecutive days while mice were drinking 15% ethanol increased pPKA levels in the CPu, but not in the NAc. In contrast to the effect of acute L-THP treatment, no differences were detected for pAKT or pERK in either striatal regions. Together, our findings suggest that reduction of ethanol drinking by L-THP treatment is possibly correlated with D2R-mediated PKA signaling in the CPu.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcohol Drinking / blood
  • Alcohol Drinking / physiopathology*
  • Alcohol Drinking / psychology
  • Animals
  • Berberine Alkaloids / pharmacology*
  • Choice Behavior / drug effects
  • Choice Behavior / physiology
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dopamine Antagonists / pharmacology*
  • Dopamine D2 Receptor Antagonists*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Male
  • Mice
  • Oncogene Protein v-akt / metabolism
  • Signal Transduction / drug effects*

Substances

  • Berberine Alkaloids
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • tetrahydropalmatine
  • Oncogene Protein v-akt
  • Cyclic AMP-Dependent Protein Kinases
  • Extracellular Signal-Regulated MAP Kinases